| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.16 | 0.0004 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0005 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.096 | 0.001 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.33 | 0.001 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.095 | 0.001 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.097 | 0.002 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.004 |